Obesity drug sales soar
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Eli Lilly https://seekingalpha.com/news/4063037-eli-lilly-stock-gains-q4-beats-obesity-drugs?source=wsb_podcast:obesity_drug_sales_soar sales forecasts. (0:16) DuPont https://seekingalpha.com/news/4063007-duponts-stock-rises-on-dividend-hike-stock-buyback?source=wsb_podcast:obesity_drug_sales_soar and launches buyback. (1:37) NYCB's https://seekingalpha.com/news/4062935-nycbs-drastic-financial-moves-followed-tense-talks-with-occ-report?source=wsb_podcast:obesity_drug_sales_soar left before it announced shock results. (2:38) Show Notes https://seekingalpha.com/news/4062707-oppenheimers-buy-vs-sell-ideas-paired-by-each-smid-sector?source=wsb_podcast:obesity_drug_sales_soar https://seekingalpha.com/news/4063082-docusign-to-shrink-headcount-company-will-stay-public-after-failed-takeover-talks?source=wsb_podcast:obesity_drug_sales_soar Episode transcripts https://seekingalpha.com/wsb?source=wsb_podcast:obesity_drug_sales_soar Sign up...
show moreShow Notes
Oppenheimer's Buy vs. Sell ideas paired by each SMID sector
DocuSign to shrink headcount; company will stay public after failed takeover talks
Episode transcripts seekingalpha.com/wsb
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Information
| Author | Seeking Alpha |
| Organization | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
